Organization bemoans rich nations that used 'most of the global supply' of shots now 'using even more of it'

Final okay could boost vaccine-hesitant people's confidence in getting the shot

Hadassah doctor hopes to allay false fears vaccine harms men’s ability to conceive, after surveying samples from before and after vaccination and finding there’s no change

Health minister defends being first country to approve 3rd shot for those older than 60: 'Any wait or delay in making the decision would cost lives'

TV polls indicate that more than 70 percent of those eligible intend to receive the booster shot

Introduction of booster shots for people aged 60+ seen as safe, but one senior doctor says it's ‘not clear enough what the real benefit is'

While health officials were worried about myocarditis among 12- to 15-year-olds, data from 200,000 monitored shows just three such cases

Gov't-appointed board gives approval to boosters after seeing data revealing drop in vaccine effectiveness over time among those above 60; Health Ministry chief's approval needed

Majority of 39 'breakthrough' cases among 1,497 monitored were mild, but research author says persistence of symptoms among minority ‘raises concern’

Strong sales of its COVID-19 shot help Pfizer nearly double its second-quarter revenue, setting it on a path to $33.5 billion in vaccine sales in 2021